Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

Ionis Pharmaceuticals, Inc. Income Tax Expense

Ionis Pharmaceuticals, Inc. (IONS) reported Income Tax Expense of $1.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-29

  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $1.26M.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $218.00K, a 87.93% increase year-over-year.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $1.48M.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $213.00K.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2025 was $1.79M.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2024 was -$6.17M, a 119.09% decline from fiscal 2023.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2023 was $32.32M, a 175.38% increase from fiscal 2022.
  • Ionis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2022 was $11.74M.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 3 month as first filedIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 6 month as first filedIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 9 month as first filedIncome Tax Expense (Benefit) 12 monthIncome Tax Expense (Benefit) 12 month as first filed
2026-06-30$1.26M
10-Q · filed 2026-07-29
$1.48M
10-Q · filed 2026-07-29
$2.96M
derived: sum of 3 quarters · filed 2026-07-29
$3.17M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$218.00K
10-Q · filed 2026-04-29
$1.70M
derived: sum of 2 quarters · filed 2026-04-29
$1.91M
derived: sum of 3 quarters · filed 2026-04-29
$1.89M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$1.69M
derived: sum of 2 quarters · filed 2026-02-26
$1.67M
derived: sum of 3 quarters · filed 2026-07-29
$1.79M
10-K · filed 2026-02-26
2025-09-30$213.00K
10-Q · filed 2025-10-29
$193.00K
derived: sum of 2 quarters · filed 2026-07-29
$308.00K
10-Q · filed 2025-10-29
-$2.38M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$20.00K
10-Q · filed 2026-07-29
$96.00K
10-Q · filed 2026-07-29
-$2.59M
derived: sum of 3 quarters · filed 2026-07-29
-$6.21M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$116.00K
10-Q · filed 2026-04-29
-$2.57M
derived: sum of 2 quarters · filed 2026-04-29
-$6.20M
derived: sum of 3 quarters · filed 2026-04-29
-$6.13M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$2.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$6.31M
derived: sum of 2 quarters · filed 2026-02-26
-$6.25M
derived: sum of 3 quarters · filed 2026-02-26
-$6.17M
10-K · filed 2026-02-26
2024-09-30-$3.62M
10-Q · filed 2025-10-29
-$3.56M
derived: sum of 2 quarters · filed 2025-10-29
-$3.48M
10-Q · filed 2025-10-29
$3.01M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$64.00K
10-Q · filed 2025-07-30
$140.00K
10-Q · filed 2025-07-30
$6.63M
derived: sum of 3 quarters · filed 2026-02-26
$13.24M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$75.00K
10-Q · filed 2025-04-30
$6.57M
derived: sum of 2 quarters · filed 2026-02-26
$13.17M
derived: sum of 3 quarters · filed 2026-02-26
$21.02M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$6.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$13.10M
derived: sum of 2 quarters · filed 2026-02-26
$20.94M
derived: sum of 3 quarters · filed 2026-02-26
$32.32M
10-K · filed 2026-02-26
2023-09-30$6.60M
10-Q · filed 2024-11-06
$14.44M
derived: sum of 2 quarters · filed 2024-11-06
$25.82M
10-Q · filed 2024-11-06
$33.92M
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30$7.84M
10-Q · filed 2024-08-01
$19.22M
10-Q · filed 2024-08-01
$27.32M
derived: sum of 3 quarters · filed 2025-02-19
$27.61M
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31$11.38M
10-Q · filed 2024-05-07
$19.48M
derived: sum of 2 quarters · filed 2025-02-19
$19.76M
derived: sum of 3 quarters · filed 2025-02-19
$22.02M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$8.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$8.38M
derived: sum of 2 quarters · filed 2025-02-19
$10.64M
derived: sum of 3 quarters · filed 2025-02-19
$11.74M
10-K · filed 2025-02-19
2022-09-30$283.00K
10-Q · filed 2023-11-02
$2.54M
derived: sum of 2 quarters · filed 2023-11-02
$3.64M
10-Q · filed 2023-11-02
$3.94M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$2.26M
10-Q · filed 2023-08-09
$3.35M
10-Q · filed 2023-08-09
$3.66M
derived: sum of 3 quarters · filed 2024-02-21
$2.35M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$1.09M
10-Q · filed 2023-05-03
$1.40M
derived: sum of 2 quarters · filed 2024-02-21
$90.00K
derived: sum of 3 quarters · filed 2024-02-21
$417.00K
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$303.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
-$1.00M
derived: sum of 2 quarters · filed 2024-02-21
-$677.00K
derived: sum of 3 quarters · filed 2024-02-21
-$551.00K
10-K · filed 2024-02-21
2021-09-30-$1.31M
10-Q · filed 2022-11-09
-$980.00K
derived: sum of 2 quarters · filed 2022-11-09
-$854.00K
10-Q · filed 2022-11-09
$340.26M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$327.00K
10-Q · filed 2022-08-09
$457.00K
10-Q · filed 2022-08-09
$341.57M
derived: sum of 3 quarters · filed 2023-02-22
$346.63M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$130.00K
10-Q · filed 2022-05-04
$341.24M
derived: sum of 2 quarters · filed 2023-02-22
$346.31M
derived: sum of 3 quarters · filed 2023-02-22
$348.39M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$341.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$346.18M
derived: sum of 2 quarters · filed 2023-02-22
$348.26M
derived: sum of 3 quarters · filed 2023-02-22
$345.19M
10-K · filed 2023-02-22
$316.73M
10-K · filed 2021-02-24
2020-09-30$5.06M
10-Q · filed 2021-11-03
$2.65M
10-Q · filed 2020-11-04
$7.15M
derived: sum of 2 quarters · filed 2021-11-03
$4.08M
10-Q · filed 2021-11-03
-$1.05M
10-Q · filed 2020-11-04
$46.38M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$2.08M
10-Q · filed 2021-08-04
-$439.00K
10-Q · filed 2020-08-05
-$988.00K
10-Q · filed 2021-08-04
-$3.70M
10-Q · filed 2020-08-05
$41.31M
derived: sum of 3 quarters · filed 2022-02-25
$26.40M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$3.07M
10-Q · filed 2021-05-05
-$3.26M
10-Q · filed 2020-05-06
$39.23M
derived: sum of 2 quarters · filed 2022-02-25
$24.32M
derived: sum of 3 quarters · filed 2022-02-25
$17.39M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$42.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$27.39M
derived: sum of 2 quarters · filed 2022-02-25
$20.46M
derived: sum of 3 quarters · filed 2022-02-25
$51.51M
10-K · filed 2022-02-25
$43.51M
10-K · filed 2020-03-02
2019-09-30-$14.91M
10-Q · filed 2020-11-04
-$21.84M
derived: sum of 2 quarters · filed 2020-11-04
$9.20M
10-Q · filed 2020-11-04
-$282.76M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$6.93M
10-Q · filed 2020-08-05
$24.12M
10-Q · filed 2020-08-05
-$267.85M
derived: sum of 3 quarters · filed 2021-02-24
-$267.39M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$31.05M
10-Q · filed 2020-05-06
-$260.92M
derived: sum of 2 quarters · filed 2021-02-24
-$260.47M
derived: sum of 3 quarters · filed 2021-02-24
-$260.11M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31-$291.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$291.51M
derived: sum of 2 quarters · filed 2021-02-24
-$291.15M
derived: sum of 3 quarters · filed 2021-02-24
-$291.14M
10-K · filed 2021-02-24
2018-09-30$452.00K
10-Q · filed 2019-11-06
$810.00K
derived: sum of 2 quarters · filed 2019-11-06
$824.00K
10-Q · filed 2019-11-06
-$6.34M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$358.00K
10-Q · filed 2019-08-08
$372.00K
10-Q · filed 2019-08-08
-$6.79M
derived: sum of 3 quarters · filed 2020-03-02
-$5.83M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$15.00K
10-Q · filed 2019-05-09
-$7.15M
derived: sum of 2 quarters · filed 2020-03-02
-$6.19M
derived: sum of 3 quarters · filed 2020-03-02
-$5.97M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$7.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$6.20M
derived: sum of 2 quarters · filed 2020-03-02
-$5.98M
derived: sum of 3 quarters · filed 2020-03-02
-$5.98M
10-K · filed 2020-03-02
2017-09-30$961.00K
10-Q · filed 2018-11-06
$1.18M
derived: sum of 2 quarters · filed 2018-11-06
$1.18M
10-Q · filed 2018-11-06
$4.12M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$222.00K
10-Q · filed 2018-08-07
$222.00K
10-Q · filed 2018-08-07
$3.15M
derived: sum of 3 quarters · filed 2019-03-01
$3.15M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$0.00
10-Q · filed 2018-05-07
$2.93M
derived: sum of 2 quarters · filed 2019-03-01
$2.93M
derived: sum of 3 quarters · filed 2019-03-01
$2.70M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$2.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$2.93M
derived: sum of 2 quarters · filed 2019-03-01
$2.70M
derived: sum of 3 quarters · filed 2019-03-01
$2.93M
10-K · filed 2019-03-01
2016-09-30$0.00
10-Q · filed 2017-11-07
-$231.00K
derived: sum of 2 quarters · filed 2017-11-07
$1.00K
10-Q · filed 2017-11-07
$373.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$231.00K
10-Q · filed 2017-08-09
$1.00K
10-Q · filed 2017-08-09
$373.00K
derived: sum of 3 quarters · filed 2018-02-28
$373.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$232.00K
10-Q · filed 2017-05-09
$604.00K
derived: sum of 2 quarters · filed 2018-02-28
$604.00K
derived: sum of 3 quarters · filed 2018-02-28
$1.39M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$372.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$372.00K
derived: sum of 2 quarters · filed 2018-02-28
$1.16M
derived: sum of 3 quarters · filed 2018-02-28
$372.00K
10-K · filed 2018-02-28
2015-09-30$0.00
10-Q · filed 2016-11-09
$789.00K
derived: sum of 2 quarters · filed 2016-11-09
$0.00
10-Q · filed 2016-11-09
-$15.41M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$789.00K
10-Q · filed 2016-08-09
$0.00
10-Q · filed 2016-08-09
-$15.41M
derived: sum of 3 quarters · filed 2017-03-01
-$14.01M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$789.00K
10-Q · filed 2016-05-05
-$16.20M
derived: sum of 2 quarters · filed 2017-03-01
-$14.80M
derived: sum of 3 quarters · filed 2017-03-01
-$13.92M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$15.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$14.01M
derived: sum of 2 quarters · filed 2017-03-01
-$13.13M
derived: sum of 3 quarters · filed 2017-03-01
-$15.41M
10-K · filed 2017-03-01
2014-09-30$1.40M
10-Q · filed 2015-11-09
$2.28M
derived: sum of 2 quarters · filed 2015-11-09
$2.00K
10-Q · filed 2015-11-09
2014-06-30$881.00K
10-Q · filed 2015-08-05
-$1.40M
10-Q · filed 2015-08-05
2014-03-31-$2.28M
10-Q · filed 2015-05-05
2013-12-31-$5.91M
10-K · filed 2016-02-26
2012-12-31-$8.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$9.11M
derived: sum of 2 quarters · filed 2015-03-02
-$9.11M
derived: sum of 3 quarters · filed 2015-03-02
-$9.11M
10-K · filed 2015-03-02
2012-09-30-$706.00K
10-Q · filed 2012-11-06
-$706.00K
derived: sum of 2 quarters · filed 2012-11-06
-$704.00K
10-Q · filed 2012-11-06
-$704.00K
derived: sum of 4 quarters · filed 2012-11-06
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
$2.00K
10-Q · filed 2012-08-06
$2.00K
derived: sum of 3 quarters · filed 2012-08-06
$2.00K
derived: sum of 4 quarters · filed 2012-11-06
2012-03-31$2.00K
10-Q · filed 2012-05-09
$2.00K
derived: sum of 2 quarters · filed 2012-05-09
$2.00K
derived: sum of 3 quarters · filed 2012-11-06
$11.00K
derived: sum of 4 quarters · filed 2012-11-06
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$0.00
derived: sum of 2 quarters · filed 2012-11-06
$9.00K
derived: sum of 3 quarters · filed 2012-11-06
$11.00K
10-K · filed 2012-02-29
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$9.00K
derived: sum of 2 quarters · filed 2012-11-06
$11.00K
10-Q · filed 2012-11-06
$101.00K
derived: sum of 4 quarters · filed 2012-11-06
2011-06-30$9.00K
10-Q · filed 2012-08-06
$11.00K
10-Q · filed 2012-08-06
$101.00K
derived: sum of 3 quarters · filed 2012-08-06
$101.00K
derived: sum of 4 quarters · filed 2012-08-06
2011-03-31$2.00K
10-Q · filed 2012-05-09
$92.00K
derived: sum of 2 quarters · filed 2012-05-09
$92.00K
derived: sum of 3 quarters · filed 2012-05-09
$94.00K
derived: sum of 4 quarters · filed 2012-05-09
2010-12-31$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$90.00K
derived: sum of 2 quarters · filed 2012-02-29
$92.00K
derived: sum of 3 quarters · filed 2012-02-29
$92.00K
10-K · filed 2012-02-29
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$2.00K
derived: sum of 2 quarters · filed 2011-11-08
$2.00K
10-Q · filed 2011-11-08
2010-06-30$2.00K
10-Q · filed 2011-08-08
$2.00K
10-Q · filed 2011-08-08
2009-12-31$2.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$3.04M
derived: sum of 2 quarters · filed 2012-02-29
$3.03M
derived: sum of 3 quarters · filed 2012-02-29
$3.19M
10-K · filed 2012-02-29
2009-09-30$724.00K
10-Q · filed 2010-11-05
$713.00K
derived: sum of 2 quarters · filed 2010-11-05
$873.00K
10-Q · filed 2010-11-05
2009-06-30-$11.00K
10-Q · filed 2010-08-09
$149.00K
10-Q · filed 2010-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10